Efficacy and tolerability of alirocumab in Austrian clinical practice - results of the non-interventional PEARL-AT study.
Curr Med Res Opin
; 36(9): 1419-1425, 2020 09.
Article
in En
| MEDLINE
| ID: mdl-32568565
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
PCSK9 Inhibitors
/
Hypercholesterolemia
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Curr Med Res Opin
Year:
2020
Document type:
Article
Affiliation country:
Austria
Country of publication:
United kingdom